This week’s episode

DNA typewriter maps family tree | 🧪 Stanford molecule turns lymphoma's driver | Long-acting HIV drug combo controls | 🧬 Editas cleared to start first | Real-world test of Google's medical | 🤖 SpaceX buys 800 MHz spectrum

Oct '26 – This week brings major progress in understanding how cells develop and in treating diseases at their genetic roots. Researchers mapped 1.3 million cells to trace development, engineered a molecule that.

Ready to play9 Oct 2026
The audio edition

DNA typewriter maps family tree | 🧪 Stanford molecule turns lymphoma's driver | Long-acting HIV drug combo controls | 🧬 Editas cleared to start first | Real-world test of Google's medical | 🤖 SpaceX buys 800 MHz spectrum

This week's NotebookLM episode

00:00--:--

Article stream

Selected articles, synthesized in order

UW Medicine Newsroom2 min read

DNA typewriter maps family tree of 1.3 million mouse embryo cells

UW Medicine scientists put a redesigned DNA Typewriter into a fertilized mouse egg, where it types a new code into each cell's DNA every time the cell divides. Reading those codes back traced the lineage of 1.3 million cells across 13.5 days, from the first split into two cells to organ formation. The Science study found cell types commit on their own schedules, with blood and retina settling early and the skin's outer layer later.

Read source
ScienceDaily2 min read

Stanford molecule turns lymphoma's driver protein into a kill switch

Stanford Medicine researchers built a two-sided molecule, TCIP3, that grabs BCL6, the protein driving many B-cell lymphomas, and links it to enzymes that switch the cell's death genes on. In mice implanted with human lymphoma, twice-daily treatment made the tumors disappear within 11 days with no obvious toxicity. The Cell study is early, and much more testing is needed before it could reach patients.

Read source
UCSF2 min read

Long-acting HIV drug combo controls virus despite drug resistance

UCSF doctors treated 46 people with HIV using long-acting lenacapavir plus cabotegravir, and nearly three-quarters had resistance that limits the only approved long-acting combo. Everyone who started with detectable virus got it under control within 13 weeks, and all stayed undetectable over a median of nearly two years. The pairing isn't approved yet and wasn't compared head-to-head with other treatments, so two clinical trials are planned.

Read source
Benzinga (GlobeNewswire)2 min read

Editas cleared to start first human trial of cholesterol gene edit

Editas Medicine has ethics and regulatory clearance in Australia to begin a Phase 1/2 trial of EDIT-401, a one-time gene edit that boosts the LDLR gene to lower LDL cholesterol in people with inherited high cholesterol. In monkeys it cut LDL by about 90 percent, and that drop has held for 10 months in an ongoing study. The company plans to start dosing this year and expects first safety data in early 2027.

Read source
Newswise (Beth Israel Deaconess Medical Center)2 min read

Real-world test of Google's medical chatbot finds no safety stops

Beth Israel Deaconess doctors had 98 primary care patients chat at home with Google's AMIE chatbot before urgent visits, with a physician watching every conversation live. None needed a safety stop, supervisors caught one hallucination, and doctors said the AI summary helped them prepare in 75 percent of the 44 cases where they read it. The Lancet study tested feasibility, not whether the chatbot improves health outcomes.

Read source
PhoneArena2 min read

SpaceX buys 800 MHz spectrum to build a fourth US carrier

SpaceX has agreed to buy up to 14 MHz of low-band 800 MHz spectrum, which most phones already support and which reaches deep indoors, to pair with its global 2 GHz mid-band spectrum. Pending FCC approval, Starlink Mobile plans a network that mixes direct-to-phone satellites with ground infrastructure, which SpaceX says would make it the first US carrier to use both. The move answers AT&T CEO John Stankey, who recently questioned whether SpaceX's plan could work.

Read source

04 — Internet: For You

What’s buzzing online right now

X · Hacker News · Tech press
IN

Viral reel claims Claude rebuilt Adobe's apps for free Instagram creator @raoulduke6133 claims someone used Claude to rebuild Adobe's apps "feature-complete" and release them free, but the claim is unverified and the app screenshot shown in the reel is labeled "MOCKUP."

@raoulduke6133

X

Claude adds live dashboards and animated explainers in beta @claudeai says Claude Dashboards and Claude Motion are in beta, letting you ask Claude to turn your data into live dashboards and your ideas into animated explainers.

@claudeai

Open original

Previous episodes

Recent briefings you may have missed

View all

Join curious readers

Stay ahead of the curve.
Three times a week.

High-signal breakthroughs in science, tech, and markets. Under 3 minutes. No noise, no politics — just the future arriving early.

Free forever · Unsubscribe anytime · Delivered by Resend